| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC2151 |
| Trial ID | NCT04033302 |
| Disease | Mature T-Cell and Nk-Cell Lymphoma | T-Cell Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD7 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies |
| Year | 2019 |
| Country | China |
| Company sponsor | Shenzhen Geno-Immune Medical Institute |
| Other ID(s) | GIMI-IRB-19005 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||